Title Minnesota Statutes, Minnesota Statutes

62J.70 DEFINITIONS. § Subdivision 1.Applicability. For purposes of sections 62J.70 to 62J.76, the terms defined in this section have the meanings given them. § Subd. 2.Health care provider or provider. "Health care provider" or "provider" means: (1) a physician, nurse, or other p…

62J.701 GOVERNMENTAL PROGRAMS. (a) Beginning January 1, 1999, the provisions in paragraphs (b) to (e) apply. (b) For purposes of sections 62J.695 to 62J.80, the requirements and other provisions that apply to health plan companies also apply to governmental programs. (c) For purp…

62J.71 PROHIBITED PROVIDER CONTRACTS. § Subdivision 1.Prohibited agreements and directives. The following types of agreements and directives are contrary to state public policy, are prohibited under this section, and are null and void: (1) any agreement or directive that prohibit…

62J.72 DISCLOSURE OF HEALTH CARE PROVIDER INFORMATION. § Subdivision 1.Written disclosure. (a) A health plan company, as defined under section 62J.70, subdivision 3, a health care network cooperative as defined under section 62R.04, subdivision 3, and a health care provider as de…

62J.73 PROHIBITION ON EXCLUSIVE ARRANGEMENTS. § Subdivision 1.Prohibition on exclusive relationships. No provider, group of providers, or health plan company shall restrict a person's right to provide health services or procedures to another provider, group of providers, or healt…

62J.74 ENFORCEMENT. § Subdivision 1.Authority. The commissioners of health and commerce shall each periodically review contracts and arrangements among health care providing entities and health plan companies they regulate to determine compliance with sections 62J.70 to 62J.73. A…

62J.76 NONPREEMPTION. Nothing in the Patient Protection Act preempts or replaces requirements related to patient protections that are more protective of patient rights than the requirements established by the Patient Protection Act. History: 1997 c 237 s 8

62J.80 RETALIATION. A health plan company or health care provider shall not retaliate or take adverse action against an enrollee or patient who, in good faith, makes a complaint against a health plan company or health care provider. If retaliation is suspected, the executive dire…

62J.805 DEFINITIONS. § Subdivision 1.Application. For purposes of sections 62J.805 to 62J.808, the following terms have the meanings given. § Subd. 2.Billing error. "Billing error" means an error in a bill from a health care provider to a patient for health treatment or services …

62J.806 POLICY FOR COLLECTION OF MEDICAL DEBT. § Subdivision 1.Requirement. A health care provider must make available to the public the health care provider's policy for collecting medical debt from patients. The policy must be made available by: (1) clearly posting the policy o…

62J.807 DENIAL OF HEALTH TREATMENT OR SERVICES DUE TO OUTSTANDING MEDICAL DEBT. (a) A health care provider must not deny medically necessary health treatment or services to a patient or any member of the patient's family or household because of current or previous outstanding med…

62J.808 BILLING ERRORS; HEALTH TREATMENT OR SERVICES. § Subdivision 1.Billing and acceptance of payment. (a) If a health care provider or health plan company determines or receives notice from a patient or other person that a bill from the health care provider to a patient for he…

62J.81 DISCLOSURE OF PAYMENTS FOR HEALTH CARE SERVICES. § Subdivision 1.Required disclosure by provider. (a) A health care provider, as defined in section 62J.03, subdivision 8, or the provider's designee as agreed to by that designee, shall, at the request of a consumer, and at …

62J.811 PROVIDER BALANCE BILLING REQUIREMENTS. § Subdivision 1.Billing requirements. (a) Each health care provider and health facility shall comply with the federal Consolidated Appropriations Act, 2021, Division BB also known as the "No Surprises Act," including any federal regu…

62J.812 PRIMARY CARE PRICE TRANSPARENCY. (a) Each provider shall maintain a list of the services over $25 that correspond with the provider's 25 most frequently billed current procedural terminology (CPT) codes, including the provider's ten most commonly billed evaluation and man…

62J.82 HOSPITAL INFORMATION REPORTING DISCLOSURE. § Subdivision 1.Required information. The Minnesota Hospital Association shall develop a web-based system, available to the public free of charge, for reporting the following, for Minnesota residents: (1) hospital-specific perform…

62J.823 HOSPITAL PRICING TRANSPARENCY. § Subdivision 1.Short title. This section may be cited as the "Hospital Pricing Transparency Act." § Subd. 2.Definition. For the purposes of this section, "estimate" means the actual price expected to be billed to the individual or to the in…

62J.824 FACILITY FEE DISCLOSURE. (a) Prior to the delivery of nonemergency services, a provider-based clinic that charges a facility fee shall provide notice to any patient, including patients served by telehealth as defined in section 62A.673, subdivision 2, paragraph (h), stati…

62J.826 MEDICAL AND DENTAL PRACTICES; CURRENT STANDARD CHARGES. § Subdivision 1.Definitions. (a) The definitions in this subdivision apply to this section. (b) "CDT code" means a code value drawn from the Code on Dental Procedures and Nomenclature published by the American Dental…

62J.83 REDUCED PAYMENT AMOUNTS PERMITTED. (a) Notwithstanding any provision of chapter 148 or any other provision of law to the contrary, a health care provider may provide care to a patient at a discounted payment amount, including care provided for free. (b) This section does n…

62J.84 PRESCRIPTION DRUG PRICE TRANSPARENCY. § Subdivision 1.Short title. This section may be cited as the "Prescription Drug Price Transparency Act." § Subd. 2.Definitions. (a) For purposes of this section, the terms defined in this subdivision have the meanings given. (b) "Bios…

62J.841 DEFINITIONS. § Subdivision 1.Scope. For purposes of sections 62J.841 to 62J.845, the following definitions apply. § Subd. 2.Consumer Price Index. "Consumer Price Index" means the Consumer Price Index, Annual Average, for All Urban Consumers, CPI-U: U.S. City Average, All …

62J.842 EXCESSIVE PRICE INCREASES PROHIBITED. § Subdivision 1.Prohibition. No manufacturer shall impose, or cause to be imposed, an excessive price increase, whether directly or through a wholesale distributor, pharmacy, or similar intermediary, on the sale of any generic or off-…

62J.843 REGISTERED AGENT AND OFFICE WITHIN THE STATE. Any manufacturer that sells, distributes, delivers, or offers for sale any generic or off-patent drug in the state must maintain a registered agent and office within the state. History: 2023 c 57 art 2 s 24

62J.844 ENFORCEMENT. § Subdivision 1.Notification. (a) The commissioner of health shall notify the manufacturer of a generic or off-patent drug and the attorney general of any price increase that the commissioner believes may violate section 62J.842. (b) The commissioner of manag…

62J.845 PROHIBITION ON WITHDRAWAL OF GENERIC OR OFF-PATENT DRUGS FOR SALE. § Subdivision 1.Prohibition. A manufacturer of a generic or off-patent drug is prohibited from withdrawing that drug from sale or distribution within this state for the purpose of avoiding the prohibition …

62J.846 SEVERABILITY. If any provision of sections 62J.841 to 62J.845 or the application thereof to any person or circumstance is held invalid for any reason in a court of competent jurisdiction, the invalidity does not affect other provisions or any other application of sections…

62J.85 CITATION. Sections 62J.85 to 62J.95 may be cited as the "Prescription Drug Affordability Act." History: 2023 c 57 art 2 s 28

62J.86 DEFINITIONS. § Subdivision 1.Definitions. For the purposes of sections 62J.85 to 62J.95, the following terms have the meanings given. § Subd. 2.Advisory council. "Advisory council" means the Prescription Drug Affordability Advisory Council established under section 62J.88.…

62J.87 PRESCRIPTION DRUG AFFORDABILITY BOARD. § Subdivision 1.Establishment. The commissioner of commerce shall establish the Prescription Drug Affordability Board, which shall be governed as a board under section 15.012, paragraph (a), to protect consumers, state and local gover…

62J.88 PRESCRIPTION DRUG AFFORDABILITY ADVISORY COUNCIL. § Subdivision 1.Establishment. The governor shall appoint a 18-member stakeholder advisory council to provide advice to the board on drug cost issues and to represent stakeholders' views. The governor shall appoint the memb…

62J.89 CONFLICTS OF INTEREST. § Subdivision 1.Definition. For purposes of this section, "conflict of interest" means a financial or personal association that has the potential to bias or have the appearance of biasing a person's decisions in matters related to the board, the advi…

62J.90 PRESCRIPTION DRUG PRICE INFORMATION; DECISION TO CONDUCT COST REVIEW. § Subdivision 1.Drug price information from the commissioner of health and other sources. (a) The commissioner of health shall provide to the board the information reported to the commissioner by drug ma…

62J.91 PRESCRIPTION DRUG PRODUCT REVIEWS. § Subdivision 1.General. Once a decision by the board has been made to proceed with a cost review of a prescription drug product, the board shall conduct the review and make a determination as to whether appropriate utilization of the pre…

62J.92 DETERMINATIONS; COMPLIANCE; REMEDIES. § Subdivision 1.Upper payment limit. (a) In the event the board finds that the spending on a prescription drug product reviewed under section 62J.91 creates an affordability challenge for the state health care system or for patients, t…

62J.93 REPORTS. Beginning March 1, 2024, and each March 1 thereafter, the board shall submit a report to the governor and legislature on general price trends for prescription drug products and the number of prescription drug products that were subject to the board's cost review a…

62J.94 ERISA PLANS AND MEDICARE DRUG PLANS. (a) Nothing in sections 62J.85 to 62J.95 shall be construed to require ERISA plans or Medicare Part D plans to comply with decisions of the board. ERISA plans or Medicare Part D plans are free to choose to exceed the upper payment limit…

62J.95 SEVERABILITY. If any provision of sections 62J.85 to 62J.94 or the application thereof to any person or circumstance is held invalid for any reason in a court of competent jurisdiction, the invalidity does not affect other provisions or any other application of sections 62…

62J.96 ACCESS TO 340B DRUGS. § Subdivision 1.Manufacturers. A manufacturer must not directly or indirectly restrict, prohibit, or otherwise interfere with the delivery of a covered outpatient drug to a pharmacy that is under contract with a 340B covered entity to receive and disp…